Vortioxetine 2-(2,6-dimethyl phenyl)sulfnyl aniline)

2-(2,6-Dimethylphenyl)sulfonamide aniline is a structurally distinct impurity of vortioxetine, characterized by a sulfonamide linkage between aniline and a 2,6-dimethyl-substituted benzene ring. This compound diverges from the parent drug by replacing the pyridine moiety with a dimethylphenyl sulfonamide, altering its electronic and steric properties. The 2,6-dimethyl substitution on the aromatic ring introduces steric hindrance, affecting solubility and reactivity profiles. This impurity arises during synthetic pathways due to competing sulfonation-methylation reactions. It serves as a critical HPLC reference standard for quantifying process-related impurities in vortioxetine active pharmaceutical ingredient (API) batches.